BioSpace News Archive

Phreesia, Inc. (NYSE: PHR) (“Phreesia”), a leading patient intake management platform, today announced the closing of its initial public offering of 10,681,423 shares of common stock (the “Shares”), consisting of 7,812,500 Shares issued and sold by Phreesia and 2,868,923 shares sold by certain of Phreesia’s existing stockholders (the “Selling Stockholders”)

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, will announce financial results for the second quarter 2019 on Thursday, August 8, 2019 after market close.

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that it will release its financial results for the second quarter and six months ended June 30, 2019 after the close of the financial markets on Tuesday, August 6, 2019.

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), today announced top-line results from its Phase 3 ENHANCE study, which evaluated pimavanserin as an adjunctive treatment in adult schizophrenia patients with persistent inadequate response to their current antipsychotic therapy.

Haemonetics Corporation announced changes to its financial reporting segments and business units.

The Board of Directors of BD has declared a quarterly dividend of $0.77 per common share, payable on September 30, 2019 to holders of record on September 9, 2019.

The Trendlines Group Ltd. (“Trendlines”) (SGX: 42T) (OTCQX: TRNLY) today announced that it has signed a Subscription Agreement with Librae Holdings Limited (“LH”), for an SGD10.88 million (USD8 million) investment.

Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company, today announced the acceptance of three abstracts for presentation at the upcoming European Society for Medical Oncology (ESMO) conference to be held from Sept. 27 to Oct. 1, 2019, in Barcelona.

Crystal River is the company’s fifth acquisition in the state of Florida and provides anesthesia services to two GI ambulatory surgery centers.

Castlight Health, Inc. (NYSE: CSLT) will release its second quarter 2019 financial results on Tuesday, July 30, 2019, after the market closes